Tech Company Financing Transactions
OncoSenX Funding Round
Private investors participated in a $3 million Seed capital raise for OncoSenX. The financing round was announced by the company on 7/9/2019.
Transaction Overview
Company Name
Announced On
7/9/2019
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Seed
Investors
Proceeds Purpose
These funds will allow us to accelerate the preclinical research necessary for us to begin phase 1 clinical development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
800 5th Ave. 4100
Seattle, WA 98104
USA
Seattle, WA 98104
USA
Phone
Undisclosed
Website
Email Address
Overview
OncoSenX targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthew Scholz
Chief Operating Officer
Eric Garcia
Chief Scientific Officer
John Lewis
VP - Bus. Development
Stephen Hilbert
Browse more venture capital transactions:
Prev: 7/9/2019: Procyrion venture capital transaction
Next: 7/9/2019: Brandable venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs